Sequential Treatment Strategy For Metastatic Colorectal Cancer: A Phase Iii Study Of Chemotherapy (Ct) With Or Without Bevacizumab (Bev) As First-Line Therapy Followed By Two Phase Iii Studies Of Ct Alone Or Ct Plus Bev With Or Without Cetuximab (Cetux) As Second-Line Therapy (Itaca Study Irst 153 01).